ASSESSMENT OF MELANOMA THERAPY RESPONSE

Described herein are methods for stratifying and evaluating melanoma treatment response in a subject using single cell RNA sequencing (scRNA-seq) and a two-step deconvolution analysis and optionally administering a treatment depending on the results. Embodiment described herein are methods for strat...

Full description

Saved in:
Bibliographic Details
Main Authors Judson-Torres, Robert L, Belote, Rachel
Format Patent
LanguageEnglish
Published 13.04.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Described herein are methods for stratifying and evaluating melanoma treatment response in a subject using single cell RNA sequencing (scRNA-seq) and a two-step deconvolution analysis and optionally administering a treatment depending on the results. Embodiment described herein are methods for stratifying and evaluating melanoma treatment response in a subject based on single cell or bulk RNA sequencing, bulk transcriptome profiling and/or transcript counting and a two-step deconvolution analysis and optionally administering a treatment depending on the results.
Bibliography:Application Number: US202217929062